In the realm of antimicrobials, macrolides stand out as a versatile class of antibiotics with a broad spectrum of activity. These drugs are characterized by their complex structure, consisting of a large macrocyclic lactone ring. This unique structure contributes to their ability to combat a diverse range of bacterial infections. Erythromycin, the prototypical macrolide, paved the way for subsequent derivatives like azithromycin and clarithromycin. Their mechanism of action involves binding to the bacterial ribosome, inhibiting protein synthesis. This interference disrupts the normal functioning of bacteria, leading to their inhibition or destruction. Macrolides find application in the treatment of respiratory tract infections, skin and soft tissue infections, and certain atypical bacterial infections. Azithromycin, in particular, is well-regarded for its wide tissue distribution and prolonged action, allowing for shorter treatment courses. While macrolides are generally well-tolerated, they are not immune to adverse effects. Gastrointestinal symptoms, liver enzyme abnormalities, and potential interactions with other medications should be considered when prescribing these antibiotics. As with any antimicrobial, prudent use and awareness of potential side effects are crucial for optimizing patient outcomes.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France